Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Emalex has secured a US patent for an orally disintegrating [...]

PolyPid is preparing to submit a New Drug Application for [...]

Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]

Polaryx Therapeutics, Inc has selected a leading contract research organization [...]

Compass Pathways has reported that its second pivotal Phase 3 [...]

Merck has announced that the US Food and Drug Administration [...]

Minovia Therapeutics has received orphan drug designation from the US [...]

Doron Therapeutics has dosed the first patients in its Phase [...]

Enterome has received Fast Track designation from the US Food [...]